Paolo Disarò

Thereson SpA engages in the research of proprietary technologies in the field of medicine. It specializes in the development of Therapeutic Magnetic Resonance for the non-invasive treatment of skin wounds and diabetic foot ulcers. The company was founded in June 2011 and is headquartered in Vimercate, Italy.

Italian Angels for Growth (IAG)is an venture capital firm founded in 2007 by Andrea Mandel Mantello, Antonio Sfiligoj, Enrico Castellano, Francesco Marini Clarelli, Lorenzo Franchini, Luigi Amati, Luigi Capello, Marco Asquini and Marco Villa. The firm is headquartered in Milan, Italy.

CellPly SRL develops and markets customized diagnostic tools for cancer treatment. The firm specializes in the design and marketing of solutions for defining the efficacy of immunotherapies and chemotherapies on cancer and immune cells. It offers a platform that analyzes ex-vivo samples and rare cells immediately after obtaining them from patients and preserving microenvironment conditions to readily provide information about tumor cell sensitivity to drugs and in-vivo status of single immune cells located close to tumor cells. The firm focuses on helping oncologists selecting the best treatment options, scientists studying cell response to therapy, and pharmaceutical companies increasing drug efficacy and rescuing drugs with limited efficacy through patient stratification. The company was founded by Massimo Bocchi and Roberto Guerrieri in 2013 and is headquartered in Bologna, Italy.

Olympus Group, Inc. provides civil engineering services. It services include civil engineering, which include multi-family podium, commercial, retail and industrial, single and multi family residential, earthworks, infrastructure studies and sewer capacity analysis and planning, surveying and specialty services. The company was founded on October 16, 2009 and is headquartered in Orangevale, CA.

Alzeca Biosciences, Inc. is a company based in Houston, TX. Alzeca is developing a proprietary intravenous contrast agent that targets Alzheimer's disease pathology. The company's targeted agent has shown the ability to detect early stage disease pathology with exceptional resolution and sensitivity using commonly available imaging techniques. The development of the agent was initiated through a collaboration between Dr. Ananth Annapragada and Dr. Jason Eriksen. The company was founded in 2012 by Jason Eriksen, Robin Mansukhani, Ananth Annapragada. The CEO is Carlo Giovanni Medici.

Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT.

Bracco Imaging SpA manufactures and develops diagnostic imaging solutions for public and private hospitals, imaging centers and private practices. The firm's services include radiology, X-ray imaging, magnetic resonance imaging and ultrasound applications. The company was founded in 1985 and is headquartered in Milan, Italy.

Bracco Imaging Scandinavia AB manufactures and distributes diagnostics equipment. The company was founded in 2006 and is headquartered in Gothenburg, Sweden.

Part of Fortrea Holdings, Inc., Fortrea Clinical Research Unit, Inc. is a company that engages in clinical research for pharmaceutical and biotechnology organizations. The company is based in Austin, TX.

Bracco Diagnostics, Inc. manufactures chemicals and allied products. It develops and markets diagnostic pharmaceutical products including Isovue X-ray contrast agent, ProHance MRI contrast agent and nuclear medicine products pharmaceuticals in North America. It is a subsidiary of Bracco SPA. The company is headquartered in Princeton, NJ

Medeor Associates Srl (Medeor Associates) is a private equity firm founded in 2007 by Andrea Pavero and Carlo Vanoli in 2007. The firm is headquartered in Milan, Italy.

LivaNova France SAS engages in wholesale of pharmaceutical products. The company was founded on July 16, 2004 and is headquartered in Châtillon, France.

Rejoint Srl manufactures and distributes orthopaedic knee replacement. The company was founded by Gian Guido Riva and is headquartered in Bologna, Italy.

NTC SRL manufactures generic drugs, nutraceutical and pharmaceutical products. It develops and produces generic drugs for specialist therapies, innovative medical devices and high quality food supplements. The company was founded by Nicola Travierso in 1997 and is headquartered in Milan, Italy.

Aggrade Ltd. manufactures pharmaceutical products. Its Aerodynamic Granulation System (AGS) technology is for the production by dry granulation of rational formulations of pharmaceuticals and nutraceuticals. The company was founded by Giovanni Politi and Vincenzo Politi and is headquartered in Camberley, the United Kingdom.

Aorticlab Sàrl manufactures medical and dental instruments and supplies. The company was founded by Franco Osta and Marco Vola in 2016 and is headquartered in Savigny, Switzerland.

Haermonics BV manufactures surgical drainage systems. Its product Continuous Postoperative Pericardial Flushing (CPPF) is a drainage and flushing system that allows safe implementation of a new clinical working method. The company was founded by David R. Koolbergen and Johan S. J. Manshanden and is headquartered in Amsterdam, the Netherlands.

Corcym Srl is an Italian medical device company that specializes in surgical solutions to fight structural heart disease. The company is based in Milan, Italy, and the CEO of the company is Christian Paolo Mazzi. With a presence in over 100 countries and approximately 850 employees, the company provides continuous support to patients, healthcare professionals, and healthcare systems worldwide.

Resalis Therapeutics SRL is a company that focuses on developing a transformative metabolic disease approach to target obesity and fatty liver disease. The company is based in Turin, Italy. The Italian company's lead program, RES-010, is a safe and convenient treatment that provides disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis. The CEO of the company is Eva Castagnetti.